有丝分裂原活化蛋白激酶：在炎症性肠病中的作用？
Mitogen activated protein kinases: a role in inflammatory bowel disease?
机构信息
Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
出版信息
Clin Exp Immunol. 2009 Dec;158(3):272-80. doi: 10.1111/j.1365-2249.2009.04033.x. Epub 2009 Sep 30.
Abstract
Since their discovery more than 15 years ago, the mitogen activated protein kinases (MAPK) have been implicated in an ever-increasingly diverse array of pathways, including inflammatory signalling cascades. Inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, are characterized by the perpetual production of inflammatory mediators. Research into the transduction pathway behind this over-production has highlighted the potential mediating role for the MAPKs and their related signalling components. This review highlights some of the research into the role for the MAPKs and their related signalling proteins in influencing the progression of IBD.
摘要
自 15 多年前被发现以来，丝裂原活化蛋白激酶 (MAPK) 已经涉及到越来越多的不同途径，包括炎症信号级联。炎症性肠病（IBD），如溃疡性结肠炎和克罗恩病，其特征是持续产生炎症介质。对这种过度产生背后的转导途径的研究强调了 MAPKs 及其相关信号成分的潜在介导作用。本文综述了 MAPKs 及其相关信号蛋白在影响 IBD 进展中的作用的一些研究。
相似文献
1
Mitogen activated protein kinases: a role in inflammatory bowel disease?有丝分裂原活化蛋白激酶：在炎症性肠病中的作用？
Clin Exp Immunol. 2009 Dec;158(3):272-80. doi: 10.1111/j.1365-2249.2009.04033.x. Epub 2009 Sep 30.
2
MAP kinases in inflammatory bowel disease.MAP 激酶在炎症性肠病中的作用。
Clin Chim Acta. 2011 Mar 18;412(7-8):513-20. doi: 10.1016/j.cca.2010.12.020. Epub 2010 Dec 23.
3
Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases.天然产物靶向丝裂原活化蛋白激酶：炎症性肠病的一种新治疗方法。
Curr Pharm Biotechnol. 2020;21(13):1342-1353. doi: 10.2174/1389201021666191216122555.
4
The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease.p38 丝裂原活化蛋白激酶在炎症性肠病发病机制中的作用。
J Dig Dis. 2011 Oct;12(5):327-32. doi: 10.1111/j.1751-2980.2011.00525.x.
5
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.p38丝裂原活化蛋白激酶：作为炎症性疾病治疗靶点的关键信号分子
Nat Rev Drug Discov. 2003 Sep;2(9):717-26. doi: 10.1038/nrd1177.
6
ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways.细胞间黏附分子-1诱导星形胶质细胞中促炎细胞因子的表达：细胞外信号调节激酶和p38丝裂原活化蛋白激酶途径的参与
J Immunol. 2000 Oct 15;165(8):4658-66. doi: 10.4049/jimmunol.165.8.4658.
7
Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.抑制p38丝裂原活化蛋白激酶和RICK/核因子κB信号传导可抑制炎症性肠病。
FASEB J. 2004 Oct;18(13):1550-2. doi: 10.1096/fj.04-1642fje. Epub 2004 Aug 2.
8
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment.分子信号阻断作为一种抑制白细胞与内皮细胞相互作用以治疗炎症性肠病的新方法。
Cell Adh Migr. 2009 Jul-Sep;3(3):296-9. doi: 10.4161/cam.3.3.9152. Epub 2009 Jul 2.
9
Targeting MAPK signalling: Prometheus' fire or Pandora's box?靶向丝裂原活化蛋白激酶信号传导：普罗米修斯之火还是潘多拉魔盒？
Curr Pharm Des. 2004;10(16):1885-905. doi: 10.2174/1381612043384420.
10
Therapeutic modulation of signal transduction pathways.信号转导通路的治疗性调控
Inflamm Bowel Dis. 2004 Feb;10 Suppl 1:S52-7. doi: 10.1097/00054725-200402001-00011.
引用本文的文献
1
miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK/ERK Signaling Pathway.miR-369-3p通过MEK/ERK信号通路改善肠上皮细胞的炎症和凋亡。
Int J Mol Sci. 2025 May 1;26(9):4288. doi: 10.3390/ijms26094288.
2
[Cimifugin ameliorates Crohn's disease-like colitis in mice by modulating Th-cell immune balance inhibiting the MAPK pathway].升麻素苷通过调节Th细胞免疫平衡和抑制丝裂原活化蛋白激酶（MAPK）途径改善小鼠克罗恩病样结肠炎
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):595-602. doi: 10.12122/j.issn.1673-4254.2025.03.17.
3
Chronic Exposure to Two Regimens of Waterpipe Smoke Elicits Lung Injury, Genotoxicity, and Mitochondrial Impairment with the Involvement of MAPKs Activation in Mice.长期暴露于两种水烟烟雾方案会引发小鼠肺损伤、遗传毒性和线粒体损伤，并伴有丝裂原活化蛋白激酶（MAPKs）激活。
Int J Mol Sci. 2025 Jan 6;26(1):430. doi: 10.3390/ijms26010430.
4
Regulatory effects of the p38 mitogen-activated protein kinase-myosin light chain kinase pathway on the intestinal epithelial mechanical barrier and the mechanism of modified Pulsatilla decoction in the treatment of ulcerative colitis.p38 丝裂原活化蛋白激酶-肌球蛋白轻链激酶通路对肠上皮机械屏障的调控作用及加味白头翁汤治疗溃疡性结肠炎的机制。
J Tradit Chin Med. 2024 Oct;44(5):885-895. doi: 10.19852/j.cnki.jtcm.20240806.006.
5
Zhumeria majdae essential oil attenuates TNBS-induced colitis in rats by regulating inflammatory and apoptotic pathways.土木香挥发油通过调控炎症和凋亡通路缓解三硝基苯磺酸诱导的大鼠结肠炎。
Inflammopharmacology. 2024 Dec;32(6):3809-3824. doi: 10.1007/s10787-024-01574-0. Epub 2024 Sep 23.
6
Protective effect of (E)-(2,4-dihydroxy)-α-aminocinnamic acid, a hydroxy cinnamic acid derivative, in an ulcerative colitis model induced by TNBS.（E）-（2,4-二羟基）-α-氨基肉桂酸，一种羟基肉桂酸衍生物，对三硝基苯磺酸诱导的溃疡性结肠炎模型的保护作用。
Biosci Rep. 2024 Oct 30;44(10). doi: 10.1042/BSR20240797.
7
Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds.核桃源生物活性化合物调控肠道炎症。
Nutrients. 2024 Aug 10;16(16):2643. doi: 10.3390/nu16162643.
8
Translational Relevance of Secondary Intracellular Signaling Cascades Following Traumatic Spinal Cord Injury.创伤性脊髓损伤后次级细胞内信号级联的转化相关性。
Int J Mol Sci. 2024 May 24;25(11):5708. doi: 10.3390/ijms25115708.
9
The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson's disease comorbidity.与炎症性肠病和帕金森病共病相关的罕见遗传变异景观。
Genome Med. 2024 May 14;16(1):66. doi: 10.1186/s13073-024-01335-2.
10
Inferring gene regulatory networks from single-cell multiome data using atlas-scale external data.利用图谱规模的外部数据从单细胞多组学数据推断基因调控网络。
Nat Biotechnol. 2025 Feb;43(2):247-257. doi: 10.1038/s41587-024-02182-7. Epub 2024 Apr 12.
本文引用的文献
1
Role of STAT3 in inflammatory bowel disease.信号转导与转录激活因子3（STAT3）在炎症性肠病中的作用。
World J Gastroenterol. 2008 Sep 7;14(33):5110-4. doi: 10.3748/wjg.14.5110.
2
Differential regulation of the antiapoptotic action of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra long (Bcl-xL) by c-Jun N-terminal protein kinase (JNK) 1-involved pathway in neuroglioma cells.在神经胶质瘤细胞中，c-Jun氨基末端蛋白激酶（JNK）1相关通路对B细胞淋巴瘤2（Bcl-2）和B细胞淋巴瘤超长型（Bcl-xL）抗凋亡作用的差异调节
Biol Pharm Bull. 2008 Sep;31(9):1686-90. doi: 10.1248/bpb.31.1686.
3
Inhibitors of c-jun-N-terminal kinase (JNK).c-Jun氨基末端激酶（JNK）抑制剂
Mini Rev Med Chem. 2008 Jul;8(8):755-66. doi: 10.2174/138955708784912120.
4
Peroxisome proliferator-activated receptor-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice.过氧化物酶体增殖物激活受体α在小鼠炎症性肠病模型中调节糖皮质激素的抗炎作用。
Shock. 2009 Mar;31(3):308-16. doi: 10.1097/SHK.0b013e31818339e7.
5
Crohn's disease: beyond antagonists of tumour necrosis factor.克罗恩病：超越肿瘤坏死因子拮抗剂
Lancet. 2008 Jul 5;372(9632):67-81. doi: 10.1016/S0140-6736(08)60995-2.
6
MAPK phosphatases as novel targets for rheumatoid arthritis.丝裂原活化蛋白激酶磷酸酶作为类风湿性关节炎的新靶点
Expert Opin Ther Targets. 2008 Jul;12(7):795-808. doi: 10.1517/14728222.12.7.795.
7
TNF: a master switch for inflammation to cancer.肿瘤坏死因子：炎症向癌症转变的主控开关
Front Biosci. 2008 May 1;13:5094-107. doi: 10.2741/3066.
8
The genetics and immunopathogenesis of inflammatory bowel disease.炎症性肠病的遗传学与免疫发病机制
Nat Rev Immunol. 2008 Jun;8(6):458-66. doi: 10.1038/nri2340.
9
Compartmentalised MAPK pathways.分隔的丝裂原活化蛋白激酶信号通路。
Handb Exp Pharmacol. 2008(186):205-35. doi: 10.1007/978-3-540-72843-6_9.
10
NF-kappaB in inflammatory bowel disease.炎症性肠病中的核因子κB
J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x.
Zotero 插件